New shoulder implant shows promise in early study
NCT ID NCT04968405
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new shoulder implant called the Catalyst CSR System in 87 people with shoulder arthritis or bone damage. The implant is designed to preserve more natural bone than traditional replacements. Researchers measured pain, movement, and implant safety over two years. The goal was to see if the device performs well and is safe for everyday use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Catalyst CSR Total Shoulder System (a bone-preserving shoulder implant)
What this could lead to
If successful, this implant could offer a less invasive option for shoulder replacement, potentially preserving more bone and improving recovery.
What could go wrong
This is a small, completed study with no control group, so results may not apply to everyone. Implant risks include infection, loosening, or need for revision surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS SHOULDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beaumont Hospital Royal Oak
Royal Oak, Michigan, 48073, United States
-
Kaiser Permanente Northwest Center for Health Research
Portland, Oregon, 97227, United States
-
Lifespan/University Orthopedics
Providence, Rhode Island, 02914, United States